Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
624
Recruiting Now
624
Top Conditions in Phase 1
NCT06493864 Phase 1
Recruiting
A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic...
Condition
Breast Cancer
Enrollment
21 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C
NCT07109518 Phase 1
Recruiting
uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
Condition
Acute Myeloid Leukemia (AML)
Enrollment
12 pts
Location
China
Sponsor
Institute of Hematology & Bloo
NCT05943496 Phase 1
Recruiting
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Unt...
Condition
Chronic Lymphocytic Leukemia
Enrollment
27 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT02977468 Phase 1
Recruiting
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Tripl...
Condition
Triple Negative Breast Cancer
Enrollment
15 pts
Location
United States
Sponsor
Eileen Connolly
NCT06799013 Phase 1
Recruiting
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo...
Condition
Vaccine
Enrollment
48 pts
Location
United States
Sponsor
HDT Bio
NCT06368960 Phase 1
Recruiting
BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
36 pts
Location
China
Sponsor
InnoBM Pharmaceuticals Co., Lt
NCT07395024 Phase 1
Recruiting
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the ...
Condition
Healthy Volunteer
Enrollment
54 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT06803680 Phase 1
Recruiting
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
90 pts
Location
United States, Australia, China
Sponsor
BeiGene
NCT06001788 Phase 1
Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Ref...
Condition
AML
Enrollment
171 pts
Location
United States, Italy, Spain
Sponsor
Kura Oncology, Inc.
NCT02987686 Phase 1
Recruiting
Topical Infliximab for Sterile Corneal Melt
Condition
Sterile Corneal Melt
Enrollment
12 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer
NCT06718738 Phase 1
Recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal C...
Condition
Colorectal Cancer (CRC)
Enrollment
9 pts
Location
China
Sponsor
Beijing Immunochina Medical Sc
NCT06535308 Phase 1
Recruiting
BnH-015B Clinical Trial in Moderate Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
92 pts
Location
South Korea
Sponsor
BnH Research
NCT06398418 Phase 1
Recruiting
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on ...
Condition
Solid Tumor, Adult
Enrollment
33 pts
Location
United States
Sponsor
Rise Therapeutics LLC
NCT06799520 Phase 1
Recruiting
A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmaco...
Condition
Systemic Lupus Erythematosus (SLE)
Enrollment
30 pts
Location
Bulgaria, Moldova, Romania
Sponsor
Otsuka Pharmaceutical Developm
NCT07195682 Phase 1
Recruiting
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Re...
Condition
Renal Cell Carcinoma
Enrollment
125 pts
Location
United States, Canada, France
Sponsor
Bristol-Myers Squibb
NCT06357182 Phase 1
Recruiting
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Dia...
Condition
Acute Myeloid Leukemia
Enrollment
24 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT06694480 Phase 1
Recruiting
Study of FID-022 in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
24 pts
Location
United States
Sponsor
Fulgent Pharma LLC.
NCT07040943 Phase 1
Recruiting
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refr...
Condition
Refractory Malignant Solid Tumors
Enrollment
9 pts
Location
China
Sponsor
West China Hospital
NCT04704271 Phase 1
Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol ...
Condition
Cannabis
Enrollment
100 pts
Location
United States
Sponsor
Yale University
NCT05866692 Phase 1
Recruiting
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
156 pts
Location
China
Sponsor
TYK Medicines, Inc
NCT07208136 Phase 1
Recruiting
A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
102 pts
Location
China
Sponsor
Jemincare
NCT06719011 Phase 1
Recruiting
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Condition
Obesity
Enrollment
177 pts
Location
United States
Sponsor
Novo Nordisk A/S
NCT05968690 Phase 1
Recruiting
Naltrexone and Propranolol Combined With Immunotherapy
Condition
Advanced Melanoma
Enrollment
12 pts
Location
United States
Sponsor
Sarah Weiss
NCT05412082 Phase 1
Recruiting
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
Condition
Locally Advanced Rectal Cancer
Enrollment
25 pts
Location
United States
Sponsor
University of Miami
NCT07232524 Phase 1
Recruiting
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Nec...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
16 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C